Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study - DocWire News

5/21/2022 12:00:00 AM3 years 9 months ago

J Hematol Oncol. 2022 May 21;15(1):67. doi: 10.1186/s13045-022-01290-8.ABSTRACTAlthough messenger RNA (mRNA) vaccines have established efficacy for

J Hematol Oncol. 2022 May 21;15(1):67. doi: 10.1186/s13045-022-01290-8. ABSTRACT Although messenger RNA (mRNA) vaccines have established efficacy for prevention of severe SARS-CoV2 infection in the… [+987 chars]

full article...